Literature DB >> 11897595

mar Operon involved in multidrug resistance of Enterobacter aerogenes.

Renaud Chollet1, Claude Bollet, Jacqueline Chevalier, Monique Malléa, Jean-Marie Pagès, Anne Davin-Regli.   

Abstract

We determined the sequence of the entire marRAB operon in Enterobacter aerogenes. It is functionally and structurally analogous to the Escherichia coli operon. The overexpression of E. aerogenes MarA induces a multidrug resistance phenotype in a susceptible strain, demonstrated by a noticeable resistance to various antibiotics, a decrease in immunodetected porins, and active efflux of norfloxacin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897595      PMCID: PMC127096          DOI: 10.1128/AAC.46.4.1093-1097.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding.

Authors:  M N Alekshun; Y S Kim; S B Levy
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

2.  A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin.

Authors:  E Dé; A Baslé; M Jaquinod; N Saint; M Malléa; G Molle; J M Pagès
Journal:  Mol Microbiol       Date:  2001-07       Impact factor: 3.501

3.  Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli.

Authors:  M A Webber; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Prevalence of the multiple antibiotic resistance operon (marRAB) in the genus Salmonella.

Authors:  N I Kunonga; R J Sobieski; S S Crupper
Journal:  FEMS Microbiol Lett       Date:  2000-06-15       Impact factor: 2.742

5.  Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA.

Authors:  T M Barbosa; S B Levy
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

6.  Most Enterobacter aerogenes strains in France belong to a prevalent clone.

Authors:  C Bosi; A Davin-Regli; C Bornet; M Mallea; J M Pages; C Bollet
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR.

Authors:  H J Linde; F Notka; M Metz; B Kochanowski; P Heisig; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

8.  Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.

Authors:  C Bornet; A Davin-Regli; C Bosi; J M Pages; C Bollet
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.

Authors:  M Oethinger; W V Kern; A S Jellen-Ritter; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

10.  Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.

Authors:  Monique Mallea; Jacqueline Chevalier; Charleric Bornet; Annie Eyraud; Anne Davin-Regli; Claude Bollet; Jean-Marie Pages
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

View more
  20 in total

1.  Aromatic acid metabolites of Escherichia coli K-12 can induce the marRAB operon.

Authors:  Lon M Chubiz; Christopher V Rao
Journal:  J Bacteriol       Date:  2010-07-16       Impact factor: 3.490

2.  Presence of multidrug-resistant enteric bacteria in dairy farm topsoil.

Authors:  J M Burgos; B A Ellington; M F Varela
Journal:  J Dairy Sci       Date:  2005-04       Impact factor: 4.034

3.  An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins.

Authors:  Myrielle Dupont; Chloë E James; Jacqueline Chevalier; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

4.  Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs.

Authors:  Hesna Yigit; Gregory J Anderson; James W Biddle; Christine D Steward; J Kamile Rasheed; Lourdes L Valera; John E McGowan; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  The eefABC multidrug efflux pump operon is repressed by H-NS in Enterobacter aerogenes.

Authors:  Muriel Masi; Jean-Marie Pagès; Claude Villard; Elizabeth Pradel
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

Review 6.  Regulation of bacterial drug export systems.

Authors:  Steve Grkovic; Melissa H Brown; Ronald A Skurray
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

7.  AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii.

Authors:  Alexey Ruzin; David Keeney; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

8.  High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.

Authors:  Frank M Kaczmarek; Fadia Dib-Hajj; Wenchi Shang; Thomas D Gootz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

9.  High incidence of multiple antibiotic resistant cells in cultures of in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Benjamin R Carone; Tao Xu; Kenan C Murphy; Martin G Marinus
Journal:  Mutat Res       Date:  2013-12-18       Impact factor: 2.433

10.  Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital.

Authors:  C De Champs; C Rich; P Chandezon; C Chanal; D Sirot; C Forestier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-18       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.